COVID-19 Funding Opportunities
Jump To:
Funding for Research from the CARES Act
Learn more about the CARES Act here.
| Agency and page number in CARES Act | CARES Appropriation Amount |
|---|---|
| p. 626 National Institute of Standards Scientific Research | • $6 M for Scientific and Technical Research funding for NISSR - Dept of Commerce |
| p. 627 National Oceanic and Atmospheric Adminstration Operations, Research, Facilities | • $20 M for Operations, Research and Facilities |
| p. 631 State & Local Law Assistance | • $850 M allocated to law enforcement agencies nationwide |
| p. 633 Scientific Research Funding: National Science Foundation (NSF) | • $75M in funding toward COVID-19 related research |
| p. 658 Scientific Research Funding: Department of Energy Office of Science (DOE) | • $99.5M in funding toward COVID-19 related research |
| p. 705 FEMA Disaster Relief Fund | • $45B appropriated to FEMA for disaster relief |
| p. 716 EPA -Science and Technology, research | • $2.25 M granted to EPA for Science and Technical Research |
| p. 719 Forest Service - Research | • $3 M appropriated to Forest Service for Research |
| p. 726 National Endowment for Arts 40% to states; 60% direct grants | • $75M appropriated to NEA; 60% of funds available for direct grants |
| p. 727 National Endowment for Humanities 40% to states; 60% direct grants | • $75M appropriated to NEA; 60% of funds available for direct grants |
| p. 731 DHHS -CDC surveillance, epidemiology, lab capacity, infection control, mitigation, communication, global response, health data surveillance and analytics, infrastructure modernization, infectious disease rapid response | • $1.5 B for surveillance,epidemiology, lab capacity, infection control, mitigation, communication, preparedness and response • $500 M global disease and response • $500 M health data surveillance and analytics, infrastructure modernization $300M infectious disease rapid response reserve fund |
| p. 733 Scientific Research Funding: National Institutes of Health (NIH) (see detail below) | • $945M in funding toward COVID-19 related research |
| p. 733 National Heart Lung Blood Institute | • $103 M appropriated for research |
| p. 734 National Institute of Allergy and Infectious Diseases | • $706M appropriated for research |
| p. 734 National Institute of Biomedical Imaging and Bioengineering | • $60 M appropriated for research |
| p. 736 Substance Abuse & Mental Health - clinic expansion, suicide prevention | • $425 M appropriated to DHHS for Certified Community Behavioral Health Clinic Expansion Grants and Suicide Prevention Programs |
| p. 746 Public Health & Social Services Emergency fund- National Stockpile, Hospital Preparedness Program, Biomedical Advanced Research, Development of vaccines, therapeutics, diagnostics, surge capacity. Blood supply chain assessment, workforce modernization, telehealth access and infrastructure, initial advanced manufacturing, novel dispensing, vaccine purchase | • $27.015 B appropriation to DHHS; $16 B National Stockpile, PPE & other equipment, drugs • $250 M Hospital Preparedness Program • $3.5 B Biomedical Advanced Research & Development • Development of vaccines, therapeutics, diagnostices, surge capacity. Blood supply chain assessment, workforce modernization, telehealth access and infrastructure |
| p. 750 Additional funding for AIDS research, poison control | • $275 M for AIDS research, poison control and other emergency funding |
| p. 753 Health care providers - Temporary structures, leasing properties, med supplies, PPE, testing supplies, increased workforce and training, EOCs, retrofitting facilities. ELIGIBLE PROVIDER SUBMITS APPLICATION TO SECTY OF HHS JUSTIFYING NEED FOR PAYMENT | • $100 B for health care providers for temporary structures, leasing properties, med supplies, PPE, testing supplies, increased workforce and training, EOCs, retrofitting facilities. |
Internal Funding Opportunities
Stanford Seed Funding
Stanford RISE – Respond, Innovate, Scale, Empower
COVID-19 Crisis Response Request for Proposals
Stanford RISE aims to respond to the COVID-19 pandemic with solutions for our community that can help people and organizations respond to the complex medical, economic, policy and societal needs of this moment and far beyond. The purpose of this request for proposals (RFP) is to complement the scope of two recently announced RFPs designed to accelerate the prototyping of innovative medicines and to enable hypothesis-driven studies on COVID-19 patients (https://chemh.stanford.edu/programs/covid-19-response).
Through this RFP, we seek to support ideas that have the potential to address health and wellness issues raised by the COVID-19 pandemic. These would include proposals on social, economic, or other disparities revealed by the pandemic, community-building at Stanford and beyond, and the fostering of partnerships that are relevant to the current crisis and will persist thereafter.
Support Provided:
Successful applicants will receive $25K-$50K (total direct) for 6-12 months.
Deadline:
All application materials must be received by June 30, 2020.
Eligibility:
- All Stanford faculty with PI eligibility and CEs with a PI waiver are welcome to apply.
- Proposals are also welcome from teams of two or more predoctoral and/or postdoctoral trainees, with the support of their advisors.
- Proposals from faculty will be separately reviewed from those submitted by trainees.
Stanford ChEM-H and the Innovative Medicines Accelerator (IMA)
COVID-19 Response: Request for Proposals for Drug and Vaccine Prototyping
COVID-19 Response: Request for Proposals for Outpatient Studies on Human Subjects
Timeline:
Proposal deadline: Friday, May 29, 2020*
*LOIs do not need to be submitted to the PI’s Contract and Grants officer in OSR or the Research Process Manager in RMG for approval. All application materials must be submitted through the online application portal: https://chemh.stanford.edu/programs/covid-19-response
Eligibility: All Stanford faculty with PI eligibility
Purpose: Stanford University’s Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. The purpose of this request for proposals (RFP) is to leverage emerging capacity and infrastructure at Stanford to address the current COVID-19 pandemic.
COVID-19 Response: Request for Proposals for Drug and Vaccine Prototyping: Through this RFP, IMA seeks to support translational research projects that will develop scalable drug screening assays, validate novel drug targets, repurpose molecules with human safety data, or engineer new reagents that will serve as drug or vaccine prototypes for COVID-19. Competitive projects will have a strong therapeutic or prophylactic hypothesis. Projects at all stages (lead discovery, lead optimization) and modalities (small molecule, large molecule) will be considered provided that the project is driven by developing a therapy or prophylaxis for COVID-19. Basic research and pre-target identification/pre-assay development research are excluded from this RFP. https://chemh.stanford.edu/covid-19-drug-and-vaccine-prototyping
COVID-19 Response: Request for Proposals for Outpatient Studies on Human Subjects: Through this RFP, IMA seeks to support research projects aimed at testing hypotheses in human subjects that, if validated, have the potential to yield powerful new tools for the modeling, diagnosis, or management of COVID-19 in individuals or populations. Competitive projects will have a strong mechanistic basis and will leverage Stanford’s newly established outpatient COVID-19 Clinical and Translational Research Unit (CTRU), where outpatients can be safely tested and/or treated.
https://chemh.stanford.edu/covid-19-outpatient-studies-human-subjects
Support Provided:
Successful applicants will receive $50K-$100K (total direct) for 6-12 months with the possibility to apply for follow-up funding, contingent upon progress and scientific needs to address the rapidly evolving COVID-19 pandemic. Projects may be fully or partially funded. Projects in the “Outpatient Studies on Human Subjects” track will have access to the COVID-19 CTRU.
Selection Process:
Proposals will be reviewed by a faculty panel knowledgeable in translational research. Projects in the “Drug and Vaccine Prototyping” track will be evaluated based on the strength of the evidence for the drug or vaccine hypothesis for the treatment or prevention of COVID-19, novelty, availability of materials and facilities, and achievable goals. Projects in the “Outpatient Studies on Human Subjects” track will be evaluated based on the proposal's potential to advance understanding of the pathogenesis, population biology, diagnosis, or management of COVID-19 in human subjects, access to and use of human subjects or samples, availability of materials and facilities, and achievable goals.
Questions and Contact Info:
Elizabeth Sefton, Ph.D. Scientific Program Manager, Stanford ChEM-H esefton@stanford.edu
Stanford Human-Centered Artificial Intelligence Center (HAI)
NIH/HHS Funding Opportunities
COVID-19 Funding and Funding Opportunities – Open Mike Blog
Dr. Michael Lauer is NIH's Deputy Director for Extramural Research, serving as the principal scientific leader and advisor to the NIH Director on the NIH extramural research program.
Resources
- Supporting Yourself and Your Trainees During the Coronavirus Pandemic - Virtual NIH Activities for Trainees Outside the NIH
- NIH Website: Coronavirus Disease 2019 (COVID-19)
- CDC Website: Coronavirus Disease 2019 (COVID-19) including its guidance for Institutes of Higher Education and for mental health and coping
- WHO Website: Coronavirus disease (COVID-19) outbreak
- General Information on NIH Extramural Response to Natural Disasters and Other Emergencies
Other Sources of Funding
- Department of Defense - Prototype Development to Combat Novel Coronavirus Disease COVID-19
- Department of Defense - Newton Award for Transformative Ideas during the COVID-19 Pandemic (BRO-20-NEWTON)
- Depatment of Defense Peer Reviewed Medical Research Program - Clinical Trial Award (for Emerging Viral Diseases and Respiratory Health)
- Depatment of Defense Peer Reviewed Medical Research Program - Investigator-Initiated Research Award (for Emerging Viral Diseases and Respiratory Health)
- Depatment of Defense Peer Reviewed Medical Research Program - Technology/Therapeutic Development Award (for Emerging Viral Diseases and Respiratory Health)
- National Science Foundation - Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) - NSF 20-052
- National Science Foundation - Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) - NSF 20-055
- Office of Biomedical Advanced Research and Development Authority (BARDA) - Broad Agency Announcement (BAA)
- Office of Biomedical Advanced Research and Development Authority (BARDA) - Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
- Assistant Secretary of the Army for Acquisition, Logistics and Technology (ASA(ALT)) - xTech COVID-19 Ventilator Challenge
- Department of State - Combatting COVID-19 Pandemic and Proliferation Threats
- Agency for Health Care Research and Quality - Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)(PA-20-070)
- Agency for Health Care Research and Quality - Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)(PA-20-072)
- Agency for Health Care Research and Quality - Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (PA-20-071)(This is a forecasted opportunity).
- The Innovative Genomics Institute (IGI) is soliciting applications for its COVID-19 Rapid Response Research Fund (IGI-COVID19-RRR). Projects prioritized for funding will have the potential for impact on the urgent challenges of the COVID-19 pandemic within a 6- to 12-month timeframe.
Faculty (or researchers with PI status) with primary appointments at UC Berkeley, UC San Francisco, UC Davis, Stanford, and equivalent local research institutions are eligible to apply.
See more info and apply: https://webportalapp.com/appform/login/igi-covid19-fund Deadline: Friday, May 1st, 2020
- The Donaghue Foundation, Greater Value Portfolio
- Borealis Philanthropy Disability Inclusion Fund (DIF), COVID-19 Rapid Response Fund Request for Proposals, May 6, 2020
- Department of State, Combatting COVID-19 Pandemic and Proliferation Threats, Timeline: Applications will be accepted until May 29, 2020
- The American Lung Association COVID-19 and Emerging Respiratory Viruses Research Awards, Timeline: Applications will be accepted until May 30, 2020
- Emergency COVID-19 Research Seed Funding, University of California Office of the President. NOTE: This program will not pay indirect costs, Stanford has agreed to waive indirect costs or this program. Please see the Pre-approved IDC Waiver Exception List
- Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunities for COVID-19-Related Enhancements to Existing PCORI-Funded Projects (3 programs)
- Program Announcement – for current Research Awardees
- Program Announcement – for current Engagement Awardees
- Program Announcement – for current Dissemination and Implementation Awardees
- FY20 Peer Reviewed Medical Research Program (PRMRP) (multiple programs)
- California Wellness Foundation - Cal Wellness Commits $4 Million to Combat the COVID-19 Pandemic
- American Heart Association - Rapid Response Grant: COVID-19 and Its Cardiovascular Impact
- Department of Defense - Prototype Development to Combat Novel Coronavirus Disease COVID-19
- National Science Foundation - Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) - NSF 20-052
- National Science Foundation - Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) - NSF 20-055
- Office of Biomedical Advanced Research and Development Authority (BARDA)
- CIRM: California Institute for Regenerative Medicine - Special Call for COVID-19 Projects
- LifeArc - Coronavirus (COVID-19) therapeutics: £10 million call for rapid deployment
- Russell Sage Foundation
- Bill & Melinda Gates Foundation - COVID-19 Therapeutics Accelerator
- The Stanford Center for Innovation in Global Health - COVID-19 Global Response Seed Grants
- Department of Defense - Newton Award for Transformative Ideas during the COVID-19 Pandemic (BRO-20-NEWTON)
- University of California Research Grants Program Office - Emergency COVID-19 Research Seed Funding
- Harrington Discovery Institute - Harrington Scholar Award for Coronavirus
- Assistant Secretary of the Army for Acquisition, Logistics and Technology (ASA(ALT)) - xTech COVID-19 Ventilator Challenge
- Fast Grants - Fast Funding for COVID-19 Science
Create Your Own Search
Click the Funding navigation menu at the top of this page.
- Find the mosaic tile entitled "Search Funding Database"
- Click More at the bottom of the tile
3. You will land on this page, select Opportunities and put your search keywords in the box.
4. You will land on the search result page. On the top left click "create new alert for this search". Fill out the search criteria.
5. You will receive emails according to what you scheduled in Step 4 above. Note the email will come with the title "do-not-reply@deepwebaccess.com", see image below.
